SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-058942
Filing Date
2022-09-26
Accepted
2022-09-26 17:00:36
Documents
17
Period of Report
2022-09-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166330-8k_adialpharm.htm   iXBRL 8-K 42874
2 PRESS RELEASE OF ADIAL PHARMACEUTICALS, INC. DATED SEPTEMBER 26, 2022 ea166330ex99-1_adialpharm.htm EX-99.1 22026
7 GRAPHIC ex99-1_001.jpg GRAPHIC 13147
8 GRAPHIC ex99-1_002.jpg GRAPHIC 6060
9 GRAPHIC ex99-1_003.jpg GRAPHIC 80224
  Complete submission text file 0001213900-22-058942.txt   426254

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adil-20220926.xsd EX-101.SCH 3702
4 XBRL DEFINITION FILE adil-20220926_def.xml EX-101.DEF 26516
5 XBRL LABEL FILE adil-20220926_lab.xml EX-101.LAB 36424
6 XBRL PRESENTATION FILE adil-20220926_pre.xml EX-101.PRE 25140
11 EXTRACTED XBRL INSTANCE DOCUMENT ea166330-8k_adialpharm_htm.xml XML 5257
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 221266469
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences